FOXM1-Mediated LINC-ROR Regulates the Proliferation and Sensitivity to Sorafenib in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the second leading cause of cancer-associated death worldwide. Indeed, despite the benefit of sorafenib in the treatment of some patients with HCC, the majority of these patients have a poor response to or intolerance of sorafenib, resulting in further tumor progres...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Yingru Zhi (Författare, medförfattare), Mubalake Abudoureyimu (Författare, medförfattare), Hao Zhou (Författare, medförfattare), Ting Wang (Författare, medförfattare), Bing Feng (Författare, medförfattare), Rui Wang (Författare, medförfattare), Xiaoyuan Chu (Författare, medförfattare)
Materialtyp: Bok
Publicerad: Elsevier, 2019-06-01T00:00:00Z.
Ämnen:
Länkar:Connect to this object online.
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_92f55a1e726b4a6f950e27c5c15452fe
042 |a dc 
100 1 0 |a Yingru Zhi  |e author 
700 1 0 |a Mubalake Abudoureyimu  |e author 
700 1 0 |a Hao Zhou  |e author 
700 1 0 |a Ting Wang  |e author 
700 1 0 |a Bing Feng  |e author 
700 1 0 |a Rui Wang  |e author 
700 1 0 |a Xiaoyuan Chu  |e author 
245 0 0 |a FOXM1-Mediated LINC-ROR Regulates the Proliferation and Sensitivity to Sorafenib in Hepatocellular Carcinoma 
260 |b Elsevier,   |c 2019-06-01T00:00:00Z. 
500 |a 2162-2531 
500 |a 10.1016/j.omtn.2019.04.008 
520 |a Hepatocellular carcinoma (HCC) is the second leading cause of cancer-associated death worldwide. Indeed, despite the benefit of sorafenib in the treatment of some patients with HCC, the majority of these patients have a poor response to or intolerance of sorafenib, resulting in further tumor progression. Exploring the mechanisms underlying sorafenib resistance is essential to the treatment of HCC. Long noncoding RNAs (lncRNAs) are known as participants in tumorigenesis. In this study, we identified that long intergenic non-protein coding RNA, regulator of reprogramming (LINC-ROR), was upregulated in HCC cell lines, which was transcriptionally activated by FOXM1. Furthermore, the sponging of miR-876-5p by LINC-ROR released FOXM1, thereby forming a positive-feedback loop. Additionally, we demonstrated that upregulation of both FOXM1 and LINC-ROR impaired the sensitivity to sorafenib in HCC cells. The role of this feedback loop was demonstrated by rescue assays. These results revealed a novel molecular feedback loop between LINC-ROR and FOXM1 and elucidated their functions in sorafenib sensitivity of HCC cell lines. Keywords: LINC-ROR, FOXM1, miR-876-5p, HCC, sorafenib, sensitivity 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Molecular Therapy: Nucleic Acids, Vol 16, Iss , Pp 576-588 (2019) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S2162253119300812 
787 0 |n https://doaj.org/toc/2162-2531 
856 4 1 |u https://doaj.org/article/92f55a1e726b4a6f950e27c5c15452fe  |z Connect to this object online.